Vertex Pharmaceuticals (VRTX) Net Income - Minority: 2011-2018
Historic Net Income - Minority for Vertex Pharmaceuticals (VRTX) over the last 5 years, with Sep 2018 value amounting to -$28.4 million.
- Vertex Pharmaceuticals' Net Income - Minority fell 133.13% to -$28.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$28.4 million, marking a year-over-year decrease of 133.13%. This contributed to the annual value of -$13.7 million for FY2017, which is 92.44% up from last year.
- According to the latest figures from Q3 2018, Vertex Pharmaceuticals' Net Income - Minority is -$28.4 million, which was up 1.01% from -$28.7 million recorded in Q2 2018.
- Vertex Pharmaceuticals' 5-year Net Income - Minority high stood at -$12.2 million for Q3 2017, and its period low was -$196.0 million during Q2 2017.
- For the 3-year period, Vertex Pharmaceuticals' Net Income - Minority averaged around -$109.7 million, with its median value being -$159.1 million (2016).
- Per our database at Business Quant, Vertex Pharmaceuticals' Net Income - Minority tumbled by 654.87% in 2016 and then spiked by 93.49% in 2017.
- Vertex Pharmaceuticals' Net Income - Minority (Quarterly) stood at -$21.2 million in 2014, then crashed by 625.60% to -$153.7 million in 2015, then decreased by 18.19% to -$181.6 million in 2016, then soared by 92.44% to -$13.7 million in 2017, then tumbled by 133.13% to -$28.4 million in 2018.
- Its Net Income - Minority was -$28.4 million in Q3 2018, compared to -$28.7 million in Q2 2018 and -$29.8 million in Q1 2018.